{"id":9604,"date":"2016-04-10T14:32:51","date_gmt":"2016-04-10T12:32:51","guid":{"rendered":"http:\/\/cms.munich-startup.net\/?p=9604"},"modified":"2016-04-10T14:32:51","modified_gmt":"2016-04-10T12:32:51","slug":"bayern-kapital-invests-in-cunesoft","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/","title":{"rendered":"Bayern Kapital invests in Cunesoft"},"content":{"rendered":"

After his Joining the Munich-based biotech company Thermosome<\/a>, sets Bavaria Capital<\/a> continues its investment tour: The venture capital company of the Free State of Bavaria is investing in Cunesoft's <\/a>seven-figure Series A growth financing.<\/strong><\/p>\n

Cunesoft GmbH, a provider of regulatory master data software for various pharmaceutical industries, has completed a seven-figure Series A investment round. In addition to lead investor Occident Group from Switzerland, Bayern Kapital and High-Tech Gr\u00fcnderfonds, both of which have been on board as investors since October 2014 as part of the seed round, are also participating again.<\/p>\n

\u201cThe modular SaaS solution offered by Cunesoft is interesting for companies of all sizes and helps customers to remain competitive,\u201d<\/p><\/blockquote>\n

explains Dr. Georg Ried, Managing Director of Bayern Kapital,<\/p>\n

\u201cCunesoft is in a Growth market<\/strong> on the go, and we're happy to continue supporting that. What makes Cunesoft special is its software solution, which is unique in the industry. Cunesoft is the first to offer a consistent and integrated application from a single source."<\/p><\/blockquote>\n

International expansion planned<\/h3>\n

With the new investment, the company wants to be Further accelerate growth<\/strong> and to expand local and international sales \u2013 especially in the US and Asia. The software-as-a-service (SaaS) company is already internationally positioned with locations in Germany, France, and India.<\/p>\n

"We are very pleased that our seed investors continue to believe in Cunesoft. With the Occident Group, we have now found an internationally networked partner,"<\/p><\/blockquote>\n

explains Rainer Schwarz, founder and CEO of Cunesoft,<\/p>\n

"With the additional capital, we will not only grow geographically but also better target the top 250 pharmaceutical and life science companies. Previously, the focus was on small and medium-sized enterprises."<\/p><\/blockquote>\n

With additional software modules, the company should also become more interesting for international corporations.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Following its investment in the Munich-based biotech company Thermosome, Bayern Kapital continues its investment spree: The venture capital firm of the Free State of Bavaria is participating in Cunesoft's seven-figure Series A growth financing. Cunesoft GmbH, a provider of regulatory master data software for various industries in the pharmaceutical sector, has completed a seven-figure Series A investment round. Alongside lead investor Occident Group from the\u2026<\/p>","protected":false},"author":26,"featured_media":9624,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1,5635],"tags":[1012,1471,52,246],"acf":[],"yoast_head":"\nBayern Kapital investiert in Cunesoft - Munich Startup<\/title>\n<meta name=\"description\" content=\"Nach seinem Einstieg beim M\u00fcnchner BioTech-Unternehmen Thermosome, setzt Bayern Kapital seine Investitionstour fort und beteiligt sich an Cunesoft.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bayern Kapital investiert in Cunesoft - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Nach seinem Einstieg beim M\u00fcnchner BioTech-Unternehmen Thermosome, setzt Bayern Kapital seine Investitionstour fort und beteiligt sich an Cunesoft.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-04-10T12:32:51+00:00\" \/>\n<meta name=\"author\" content=\"Simon Tischer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simon Tischer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/\",\"name\":\"Bayern Kapital investiert in Cunesoft - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/04\/tax-468440_1280-e1460035917239.jpg\",\"datePublished\":\"2016-04-10T12:32:51+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d\"},\"description\":\"Nach seinem Einstieg beim M\u00fcnchner BioTech-Unternehmen Thermosome, setzt Bayern Kapital seine Investitionstour fort und beteiligt sich an Cunesoft.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/04\/tax-468440_1280-e1460035917239.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/04\/tax-468440_1280-e1460035917239.jpg\",\"width\":1280,\"height\":611},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bayern Kapital investiert in Cunesoft\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d\",\"name\":\"Simon Tischer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g\",\"caption\":\"Simon Tischer\"},\"description\":\"Von Dezember 2015 bis Juni 2023 war Simon Tischer als Redakteur f\u00fcr Munich Startup t\u00e4tig.\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/tischer\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2016\/04\/tax-468440_1280-e1460035917239.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"611\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bayern Kapital invests in Cunesoft - Munich Startup","description":"After joining the Munich-based biotech company Thermosome, Bayern Kapital continues its investment spree and acquires a stake in Cunesoft.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/","og_locale":"en_US","og_type":"article","og_title":"Bayern Kapital investiert in Cunesoft - Munich Startup","og_description":"Nach seinem Einstieg beim M\u00fcnchner BioTech-Unternehmen Thermosome, setzt Bayern Kapital seine Investitionstour fort und beteiligt sich an Cunesoft.","og_url":"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2016-04-10T12:32:51+00:00","author":"Simon Tischer","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Simon Tischer","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/","url":"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/","name":"Bayern Kapital invests in Cunesoft - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/04\/tax-468440_1280-e1460035917239.jpg","datePublished":"2016-04-10T12:32:51+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d"},"description":"After joining the Munich-based biotech company Thermosome, Bayern Kapital continues its investment spree and acquires a stake in Cunesoft.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/04\/tax-468440_1280-e1460035917239.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/04\/tax-468440_1280-e1460035917239.jpg","width":1280,"height":611},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/en\/9604\/bayern-kapital-invests-in-cunesoft\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Bayern Kapital investiert in Cunesoft"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d","name":"Simon Tischer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g","caption":"Simon Tischer"},"description":"From December 2015 to June 2023, Simon Tischer worked as an editor for Munich Startup.","url":"https:\/\/cms.munich-startup.net\/en\/author\/tischer\/"}]},"og_image":[{"width":1280,"height":611,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2016\/04\/tax-468440_1280-e1460035917239.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1460292616:26","_edit_last":"26","_yoast_wpseo_focuskw":"Cunesoft","_yoast_wpseo_metadesc":"Nach seinem Einstieg beim M\u00fcnchner BioTech-Unternehmen Thermosome, setzt Bayern Kapital seine Investitionstour fort und beteiligt sich an Cunesoft.","_yoast_wpseo_linkdex":"81","_thumbnail_id":"9624","wbounce_status":"","_yoast_wpseo_primary_category":"","_yoast_wpseo_focuskw_text_input":"Cunesoft","_yoast_wpseo_content_score":"","ms_image_format":"","_ms_image_format":"","ms_dachzeile":"","_ms_dachzeile":"","ms_bump_post_date":"","_ms_bump_post_date":"","guest_author_name":"","_guest_author_name":"","guest_author_image":"","_guest_author_image":"","guest_author_description":"","_guest_author_description":"","ms_post_image_caption":"","_ms_post_image_caption":"","ms_post_image_credit":"","_ms_post_image_credit":"","suppress_startupbox":"","_suppress_startupbox":"","_yoast_wpseo_estimated-reading-time-minutes":"","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/9604"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=9604"}],"version-history":[{"count":0,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/9604\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/9624"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=9604"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=9604"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=9604"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}